Movement Disorders (revue) - Checkpoint (Ncbi)

Index « Mesh.i » - entrée « Neuromuscular Agents »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Neuroma, Acoustic < Neuromuscular Agents < Neuromuscular Diseases  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 90.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000015 (1999) R. Chen [États-Unis] ; B I Karp ; S R Goldstein ; W. Bara-Jimenez ; Z. Yaseen ; M. HallettEffect of muscle activity immediately after botulinum toxin injection for writer's cramp.
000022 (1999) E K Tan [États-Unis] ; Joseph Jankovic [États-Unis]Bilateral hemifacial spasm: a report of five cases and a literature review.
000145 (1999) P. Ka Ovsk [République tchèque] ; H. Streitová ; M. Bares ; H. HortováTreatment of facial and orolinguomandibular tardive dystonia by botulinum toxin A: evidence of a long-lasting effect.
000411 (2000) D. Dressler [Allemagne] ; U. Zettl ; R. Benecke ; H. BigalkeCan intravenous immunoglobulin improve antibody-mediated botulinum toxin therapy failure?
000412 (2000) D. Dressler [Allemagne] ; M. Wittstock ; R. BeneckeTreatment of persistent hemiballism with botulinum toxin type A.
000422 (2001) R R Sloop [États-Unis] ; D. Cole ; M C PatelMuscle paralysis produced by botulinum toxin type A injection in treated torticollis patients compared with toxin naive individuals.
000588 (2001) C. Cordivari [Royaume-Uni] ; V P Misra ; S. Catania ; A J LeesTreatment of dystonic clenched fist with botulinum toxin.
000593 (2001) J. Müller [Autriche] ; G. Ebersbach ; J. Wissel ; Werner Poewe [Autriche]Dynamic balance function in phasic cervical dystonia following Botulinum toxin therapy.
000668 (2002) Charles H. Adler [États-Unis] ; Stewart A. Factor ; Mitchell Brin ; Kapil D. SethiSecondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia.
000669 (2002) C. Detrembleur [Belgique] ; T M Lejeune ; A. Renders ; P Y K. Van Den BerghBotulinum toxin and short-term electrical stimulation in the treatment of equinus in cerebral palsy.
000670 (2002) Dirk Dressler [Royaume-Uni] ; Hans BigalkeBotulinum toxin antibody type A titres after cessation of botulinum toxin therapy.
000687 (2002) Drake D. DuaneCervical dystonia.
000B77 (2003) Markus Naumann ; A Peter MooreLong-term safety of botulinum toxin type A.
000C67 (2003) Jörg Müller [Autriche] ; Markus Kofler ; Gregor K. Wenning ; Klaus Seppi ; Josep Valls-Solé ; Werner Poewe [Autriche]Auditory startle response in cervical dystonia.
000C69 (2003) Carolyn Kwak [États-Unis] ; Kevin Dat Vuong ; Joseph Jankovic [États-Unis]Premonitory sensory phenomenon in Tourette's syndrome.
000C74 (2003) Craig E. Hou [États-Unis] ; Bradley L. Schlaggar ; Brad A. RacetteDystonia in a patient with ring chromosome 21.
000D49 (2004) Colum D. Mackinnon [États-Unis] ; Miodrag Velickovic ; Cristina Drafta ; Alexander Hesquijarosa ; Mitchell F. BrinCorticospinal excitability accompanying ballistic wrist movements in primary dystonia.
000D52 (2004) Peter Haussermann [Allemagne] ; Stefanie Marczoch ; Christiane Klinger ; Michael Landgrebe ; Bastian Conrad ; Andres Ceballos-BaumannLong-term follow-up of cervical dystonia patients treated with botulinum toxin A.
000D70 (2004) John A. Chaddock [Royaume-Uni] ; John R. Purkiss ; Frances C G. Alexander ; Sarah Doward ; Sarah J. Fooks ; Lorna M. Friis ; Yper H J. Hall ; Elizabeth R. Kirby ; Nicola Leeds ; Hilary J. Moulsdale ; Anthony Dickenson ; G Mark Green ; Wahida Rahman ; Rie Suzuki ; Michael J. Duggan ; Conrad P. Quinn ; Clifford C. Shone ; Keith A. FosterRetargeted clostridial endopeptidases: inhibition of nociceptive neurotransmitter release in vitro, and antinociceptive activity in in vivo models of pain.
000D73 (2004) Antonio Currà ; Carlo Trompetto ; Giovanni Abbruzzese ; Alfredo BerardelliCentral effects of botulinum toxin type A: evidence and supposition.
000D74 (2004) Kai Wohlfarth [Allemagne] ; Knut Kampe ; Hans BigalkePharmacokinetic properties of different formulations of botulinum neurotoxin type A.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Neuromuscular Agents" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Neuromuscular Agents" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Neuromuscular Agents
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024